Leonard R C, Lucraft H H, Proctor S J, Allan N C, Dawson A A, Leonard R C, Lucraft H H, McGillivray J B, Parker A C, Prescott R J
Department of Clinical Oncology, Western General Hospital, Edinburgh.
Scott Med J. 1988 Dec;33(6):360-2. doi: 10.1177/003693308803300604.
A novel cytotoxic drug combination, PEEC, has been tested in the initial or salvage treatment of lymphomas. The PEEC combination alone is active in high grade or intermediate grade NHL with two complete and two partial remissions out of four patients so treated. When combined with standard CHOP therapy using an alternating regime, seven out of 11 patients obtained a complete remission and four partial remission. Ten patients were well, off treatment, beyond one year from presentation. The combination was less impressive, however, as salvage therapy with two partial responses in a heavily pre-treated group of nine patients.
一种新型细胞毒性药物组合PEEC已在淋巴瘤的初始治疗或挽救治疗中进行了测试。单独使用PEEC组合对高级别或中级别非霍奇金淋巴瘤有活性,接受治疗的4例患者中有2例完全缓解,2例部分缓解。当与采用交替方案的标准CHOP疗法联合使用时,11例患者中有7例获得完全缓解,4例部分缓解。10例患者病情良好,停止治疗,自就诊起超过一年。然而,作为挽救疗法,该组合在9例经过大量预处理的患者中仅有2例部分缓解,效果不太理想。